Ferriprox® - Deferiprone
Description
pulled from site's meta descriptionFerriprox® (deferiprone) is an iron chelator indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.
This is an automatically generated AboutUs page for DeferIProne.com. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
Categories:
- AboutUs AutoGen
- ferriprox
- deferiprone
- l1
- hydroxypyridinone
- hydroxypyridinones
- iron
- overload
- chelator
- chelation
- therapy
- oral
- tablet
- apotex
- transfusion
- dependant
- thalassemia
- thalassaemia
- blood
- hemoglobin
- haemoglobin
- ferritin
- transferrin
- liver
- hepatocytes
- hemosiderin
- haemosiderin
- apotransferrin
- divalent
- metal
- transporter
- ferroportin
- concentration
- lic
- fibrosis
- hepatic
- magnetic
- resonance
- imaging
- mri
- superconducting
- quantum
- interference
- device
- squid
- heart
- cardiomyopathy
- arrhythmia
- ventricular
- function
- impaired
- spleen
- splenectomy
- plenectomized
- failure
- cardioprotective
- cardioprotection
- oxidation
- reduction
- redox
- hydroxy
- oxidative stress
- reactive
- oxygen
- species
- ros
- free radicals
- non-transferrin bound
- ntbi
- beta thalassemia
- beta thalassaemia
- alpha thalassemia
- alpha thalassaemia
- hemoglobinopathies
- haemoglobinopathies
- e-beta
- haemoglobin h
- disease
- trait
- silent
- carrier
- deletion
- mutation
- abnormality
- genetic
- chromosome 11
- chromosomen 16
- globin
- globins
- chain
- chains
- emea
- ethalas
- icl
- icl 670a
- novartis
- igisto
- deferoxamine
- desferrioxamine
- desferal
- subcutaneous
- pump
- injection
- siderophore
- hexadentate
- bidentate
- tridentate
- ligand
- coordination